News

By Janet WhiteBioForward Board MemberDirector of Strategic Portfolio Management, Promega With the rollercoaster of a year we’ve all experienced, the recently released Wisconsin Biohealth: Industry Landscape and Economic Impact Report has been a welcome bright spot highlighting the amazing successes of our region’s biohealth companies and organizations. Simply put, the biohealth industry is a leading […]

On April 16, 2020, Wisconsin Secretary-designee of the Department of Health Services, Andrea Palm, issued Emergency Order #28 at the direction of Governor Tony Evers. This new Order extends Wisconsin’s “Safer at Home” Order until 8:00 a.m. on May 26, 2020, or until a superseding order is issued, and modifies the original order. The original Safer at Home Order issued on March 25, Emergency Order #12, remains in effect until April 24, 2020.

BioForward is actively engaged with community partners, elected officials, state agencies and industry partners to meet the challenges of combating the coronavirus and demonstrating that Wisconsin can help lead the nation through this healthcare crisis. PPE Focus Eight Madison-area community providers serving people with developmental disabilities and seniors received much-needed PPE as they battle the […]

Read the full press release here Janesville-based nuclear technology company SHINE Medical Technologies said Wednesday it has begun selling a therapeutic isotope it produces that’s used to treat cancers. SHINE recently announced it made its first commercial sales of lutetium-177, or Lu-177, to multiple customers. In addition to neuroendocrine cancers, the isotope can be used […]

Read the full press release Macrophages, cells that help engulf and destroy harmful organisms in the body, tend to be characterized as the Jekyll and Hyde of the immune system. Macrophages are essential first responders in fighting off infections and marshalling other immune cells to the scene. But they also play a major role in […]

Read the full press release  In a recent prospective, blinded study, the novel Versiti PF4-dependent P-selectin expression assay (PEA) was found to be highly accurate for the diagnosis of heparin-induced thrombocytopenia (HIT), a life-threatening, pro-thrombotic, antibody-mediated disorder that can cause blood clots, resulting in heart attacks, strokes and limb amputation. Further results of the study, […]

Read the full press release here A team of researchers at the University of Wisconsin–Madison is part of a new multi-institution effort to better understand Alzheimer’s disease in adults with Down syndrome. Adults with Down syndrome are at high risk for developing Alzheimer’s disease beginning in their late 40s, because of their unique biology. The […]